Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Apr 1;159(4):1058–1069. doi: 10.1084/jem.159.4.1058

Binding specificity of serum amyloid P component for the pyruvate acetal of galactose

PMCID: PMC2187281  PMID: 6707579

Abstract

Serum amyloid P component (SAP) is a normal plasma protein that is of interest because of its presence in amyloid deposits, its presence in normal human glomerular basement membrane, and its stable evolutionary conservation. It has calcium-dependent ligand-binding specificity for amyloid fibrils, fibronectin (Fn), C4-binding protein (C4bp), and agarose. Although the binding to agarose, a linear galactan hydrocolloid derived from some marine algae, is unlikely per se to be related to the physiological function of SAP, it does provide a model system in which to explore the precise ligand requirements of SAP. We report here that the amount of SAP from human, mouse, and plaice (Pleuronectes platessa L.) serum able to bind to agarose from different sources reflect precisely their pyruvate content. Methylation with diazomethane of the carboxyl groups in the pyruvate moiety of agarose completely abolishes SAP binding to agarose. The pyruvate in agarose exists as the 4,6-pyruvate acetal of beta-D-galactopyranose. We have therefore synthesized this galactoside, using a novel procedure, established its structure by analysis of its nuclear magnetic resonance spectra, and shown that it completely inhibits all known calcium- dependent binding reactions of SAP. The R isomer of the cyclic acetal, methyl 4,6-O-(1-carboxyethylidene)-beta-D-galactopyranoside (MO beta DG) was effective at millimolar concentration and was more potent than its noncyclic analogue, while pyruvate, D-galactose, and methyl beta-D- galactopyranoside were without effect. The autologous protein ligands of SAP presumably, therefore express a structural determinant(s) that stereochemically resembles MO beta DG. Availability of this specific, well-characterized, low molecular weight ligand for SAP should facilitate further investigation of the function of SAP and its role in physiological and pathophysiological processes.

Full Text

The Full Text of this article is available as a PDF (892.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. K., Mole J. E. Large scale isolation and partial primary structure of human plasma amyloid P-component. Ann N Y Acad Sci. 1982;389:216–234. doi: 10.1111/j.1749-6632.1982.tb22139.x. [DOI] [PubMed] [Google Scholar]
  2. Baltz M. L., de Beer F. C., Feinstein A., Munn E. A., Milstein C. P., Fletcher T. C., March J. F., Taylor J., Bruton C., Clamp J. R. Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci. 1982;389:49–75. doi: 10.1111/j.1749-6632.1982.tb22125.x. [DOI] [PubMed] [Google Scholar]
  3. Binette P., Binette M., Calkins E. The isolation and identification of the P-component of normal human plasma proteins. Biochem J. 1974 Oct;143(1):253–254. doi: 10.1042/bj1430253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Breathnach S. M., Melrose S. M., Bhogal B., de Beer F. C., Dyck R. F., Tennent G., Black M. M., Pepys M. B. Amyloid P component is located on elastic fibre microfibrils in normal human tissue. Nature. 1981 Oct 22;293(5834):652–654. doi: 10.1038/293652a0. [DOI] [PubMed] [Google Scholar]
  5. Dyck R. F., Lockwood C. M., Kershaw M., McHugh N., Duance V. C., Baltz M. L., Pepys M. B. Amyloid P-component is a constituent of normal human glomerular basement membrane. J Exp Med. 1980 Nov 1;152(5):1162–1174. doi: 10.1084/jem.152.5.1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Haupt H., Heimburger N., Kranz T., Baudner S. Humanserumproteine mit hoher Affinität zu Carboxymethyl-Cellulose. 3. Physikalisch-chemische und immunologische Charakterisierung eines metallbindenden 9,5S- 1-Glykoproteins (CM-Protein 3. Hoppe Seylers Z Physiol Chem. 1972 Dec;353(12):1841–1849. [PubMed] [Google Scholar]
  7. Kula R. W., Engel W. K., Line B. R. Scanning for soft-tissue amyloid. Lancet. 1977 Jan 8;1(8002):92–93. doi: 10.1016/s0140-6736(77)91102-3. [DOI] [PubMed] [Google Scholar]
  8. Pepys M. B., Baltz M. L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212. doi: 10.1016/s0065-2776(08)60379-x. [DOI] [PubMed] [Google Scholar]
  9. Pepys M. B., Baltz M. L., de Beer F. C., Dyck R. F., Holford S., Breathnach S. M., Black M. M., Tribe C. R., Evans D. J., Feinstein A. Biology of serum amyloid P component. Ann N Y Acad Sci. 1982;389:286–298. doi: 10.1111/j.1749-6632.1982.tb22144.x. [DOI] [PubMed] [Google Scholar]
  10. Pepys M. B., Dash A. C., Ashley M. J. Isolation of C-reactive protein by affinity chromatography. Clin Exp Immunol. 1977 Oct;30(1):32–37. [PMC free article] [PubMed] [Google Scholar]
  11. Pepys M. B., Dash A. C., Fletcher T. C., Richardson N., Munn E. A., Feinstein A. Analogues in other mammals and in fish of human plasma proteins, C-reactive protein and amyloid P component. Nature. 1978 May 11;273(5658):168–170. doi: 10.1038/273168a0. [DOI] [PubMed] [Google Scholar]
  12. Pepys M. B., Dash A. C. Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet. 1977 May 14;1(8020):1029–1031. doi: 10.1016/s0140-6736(77)91260-0. [DOI] [PubMed] [Google Scholar]
  13. Pepys M. B., De Beer F. C., Milstein C. P., March J. F., Feinstein A., Butress N., Clamp J. R., Taylor J., Bruton C., Fletcher T. C. C-reactive protein and serum amyloid P component in the plaice (Pleuronectes platessa L.), a marine teleost, are homologous with their human counterparts. Biochim Biophys Acta. 1982 May 21;704(1):123–133. doi: 10.1016/0167-4838(82)90139-x. [DOI] [PubMed] [Google Scholar]
  14. Pepys M. B., Dyck R. F., de Beer F. C., Skinner M., Cohen A. S. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol. 1979 Nov;38(2):284–293. [PMC free article] [PubMed] [Google Scholar]
  15. Pepys M. B. Isolation of serum amyloid P-component (protein SAP) in the mouse. Immunology. 1979 Jul;37(3):637–641. [PMC free article] [PubMed] [Google Scholar]
  16. Pras M., Schubert M., Zucker-Franklin D., Rimon A., Franklin E. C. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968 Apr;47(4):924–933. doi: 10.1172/JCI105784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Scharfstein J., Ferreira A., Gigli I., Nussenzweig V. Human C4-binding protein. I. Isolation and characterization. J Exp Med. 1978 Jul 1;148(1):207–222. doi: 10.1084/jem.148.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Urry D. W. Arterial mesenchyme and arteriosclerosis. Studies on the conformation and interaction of elastin. Adv Exp Med Biol. 1974;43(0):211–243. [PubMed] [Google Scholar]
  19. Vuento M., Vaheri A. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J. 1979 Nov 1;183(2):331–337. doi: 10.1042/bj1830331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Westermark P., Shirahama T., Skinner M., Brun A., Cameron R., Cohen A. S. Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids. Lab Invest. 1982 May;46(5):457–460. [PubMed] [Google Scholar]
  21. de Beer F. C., Baltz M. L., Holford S., Feinstein A., Pepys M. B. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J Exp Med. 1981 Oct 1;154(4):1134–1139. doi: 10.1084/jem.154.4.1134. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES